Home › Targets › IGF-1

IGF-1 (1 companies · 2 programs)

Companies with an active program directed at IGF-1.

Eton Pharmaceuticals, Inc. ETON

INCRELEX — Severe Primary IGF-1 Deficiency Approved
INCRELEX — Epileptic Spasms